Abstract Submission

Abstract Submission Guidelines

We invite all participants to submit their original research abstracts for presentation at the congress. Please follow the guidelines below to ensure your submission meets the required standards:

• Abstracts must be written in English.
• Submissions must be original and not previously published.
• The abstract should be approximately 3,000 characters in length.
• Please structure your abstract using the following format:
  • Introduction and Objectives
  • Materials and Methods
  • Results
  • Conclusions
• Do not use commercial drug names, brand names, or registered trademarks. Refer to medications by their active substance only.
   

Abstract Submission Deadline: September 5, 2025